Clinical Trials
9 trialsNCT06812871 2026-04-02
High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
Sun Yat-sen University
Phase 2 Completed
NCT05286684 2026-03-18
Exo-LCR
Centre Oscar Lambret
Phase NA Completed
NCT03719768 2026-03-02
Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT04343573 2026-02-27
Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT06592092 2026-01-29
Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Completed
NCT01373710 2025-11-24
HIT
Institut Curie
Phase 1/2 Completed
NCT07239102 2025-11-20
Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Beijing Tiantan Hospital
Completed
NCT02939300 2025-11-14
Ipilimumab and Nivolumab in Leptomeningeal Metastases
Massachusetts General Hospital
Phase 2 Completed
NCT04420598 2025-06-24
DEBBRAH
MedSIR
Phase 2 Completed